coagulogram

DIAGNOSTIC_TEST2 trials

Sponsors

Samara State Medical University, Universidade Estadual de Campinas (UNICAMP)

Conditions

Acute Myeloid Leukemia, AdultCardiotoxicityEndothelial DysfunctionRecurrent Malignant Neoplasm of Bladder

Phase 2

Effects of Oncotherad Immunotherapy in the Treatment of Bacillus Calmette-Guérin (BCG)-Recurrent and Relapsed Non-Muscle Invasive Bladder Cancer

RecruitingRBR-6swqd2

Universidade Estadual de Campinas (UNICAMP)Recurrent Malignant Neoplasm of Bladder

Start: 2018-08-17Updated: 2025-10-27

Unknown Phase

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

RecruitingNCT05703126

Samara State Medical UniversityAcute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction

Start: 2022-12-01End: 2025-08-03Target: 100Updated: 2024-11-05

Related Papers

Relevance of immune tumor microenvironment and its interaction with HABP4 and SERBP1 proteins in bladder cancer.

Journal of Clinical Oncology2024-06-011 citations

Antitumor mechanisms of OncoTherad (MRB-CFI-1) nanoimmunotherapy involving monoamine oxidases: Clinical implications in BCG-unresponsive non-muscle invasive bladder cancer.

Journal of Clinical Oncology2024-06-011 citations

Monoamine oxidase as a potential target for the development of new therapeutic strategies for bladder cancer.

Journal of Clinical Oncology2023-06-012 citations

Clinical implications of T-Cells CX3CR1+, Toll-like Receptor 4 signaling pathway, and immune checkpoints in Non-Muscle Invasive Bladder Cancer

Brazilian Journal of Health Review2023-04-272 citations

Crosstalk among T-cell CX3CR1, immune checkpoints and toll-like receptor 4 signaling pathway in BCG-unresponsive nonmuscle invasive bladder cancer: Mechanism of action of OncoTherad Nano-Immunotherapy.

Journal of Clinical Oncology2022-06-012 citations

Safety and Efficacy of OncoTherad Nano-immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer

Journal of Physics Conference Series2021-06-016 citations

Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Guérin-unresponsive non–muscle invasive bladder cancer: Results from phase I/ II study.

Journal of Clinical Oncology2020-05-206 citations